A US court has certified a nationwide third party payor class in a lawsuit involving Eli Lilly’s former diabetes drug Actos.

People regain weight after stopping the injections since the medication suppresses appetite and increases feelings of fullness. For many Kenyans taking weight-loss injections, Ozempic, Wegovy and ...

California is denying popular and effective weight loss drugs to poor people — likely to spite President Donald Trump, who ...

Study shows heart benefits from GLP-1 drugs don't last if you stop taking them.

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

SCHOOL CARE SAYS THE COST OF HEALTH CARE IS UP NATIONWIDE. AND HERE IN NEW HAMPSHIRE, THE NONPROFIT SAW A RISE IN CLAIMS COMING IN OVER $50,000 FOR CANCER CARE AND SPECIALTY MEDICATIONS LIKE GLP ONE.

Ingredient giant Ingredion has partnered with AI protein discovery platform Shiru to commercialise next-gen prebiotics for the GLP-1-fuelled gut health era.

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound ...

Researchers say many patients stop GLP‑1 weight loss drugs within a year. Nearly half maintain weight loss through lifestyle changes, other treatments or surgery.

A Webb City woman experienced severe illness after accidentally overdosing on GLP-1 medication, which she hopes will serve as a warning to others about the potential negative effects of the drug.

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

When these drugs first became popular, there was a lot of public commentary that claimed taking a GLP-1 was linked with a higher risk of suicide. That sparked an investigation by the Food and Drug ...